✦ LIBER ✦

18 A phase 2 study to assess antiviral response, safety, and pharmacokinetics of albuferon™ in IFN-α NA1VE subjects with genotype 1 chronic hepatitis C

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

313 A 1/2phase study to evaluate the pha

✍ V. Balan; M. Sulkowski; D. Nelson; G. Everson; T. Bambury; J. Recta; J. Zhong; H 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

A phase 2 study to evaluate the antivira

✍ Vincent G. Bain; Kelly D. Kaita; Eric M. Yoshida; Mark G. Swain; E. Jenny Heathc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 198 KB

IFN-stimulated Gene Expression Is a Usef

✍ María Sara Sixtos-Alonso; Fausto Sánchez-Muñoz; Juan Francisco Sánchez-Ávila; Ro 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 114 KB

A Double-blind, randomized, placebo-cont

✍ Gardner, Stephen; Cutrell, Amy; Elko-Simms, Cindy; Adkison, Kimberly; Hamatake, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

15 TELAPREVIR (TVR) q8h OR q12h COMBINED

✍ M. Colombo; M.G. Rumi; G. Carosi; M. Puoti; P. Marcellin; X. Forns; T. Göser; P. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

751d SVR Results of Prove3, a Phase 2B C

✍ Adrian M. Di Bisceglie; Andrew M.J. Muir; Nathalie Adda; Ira M. Jacobson; Nezam 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 146 KB